Get the Stockscreener App
73.83
0.26%
0.19
After Hours:
73.76
-0.07
-0.09%
Livanova Plc stock is traded at $73.83, with a volume of 418.01K.
It is up +0.26% in the last 24 hours and up +13.27% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$73.64
Open:
$73.77
24h Volume:
418.01K
Relative Volume:
0.48
Market Cap:
$4.06B
Revenue:
$1.39B
Net Income/Loss:
$-242.49M
P/E Ratio:
-16.50
EPS:
-4.4759
Net Cash Flow:
$173.29M
1W Performance:
+5.47%
1M Performance:
+13.27%
6M Performance:
+33.53%
1Y Performance:
+70.98%
1-Day Range:
$73.58
$74.41
1-Week Range:
$70.39
$74.41
52-Week Range:
$41.02
$74.41
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
73.83 | 4.05B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
LivaNova names Stefano Folli as president, CP - Medical Buyer
Why (LIVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
LIVN Technical Analysis & Stock Price Forecast - Intellectia AI
LivaNova appoints Stefano Folli to lead its cardiopulmonary business unit - MSN
Paradice Investment Management LLC's LivaNova PLC(LIVN) Holding History - GuruFocus
LivaNova names Stefano Folli as cardiopulmonary president - Investing.com UK
LivaNova appoints Franco Poletti as President, Cardiopulmonary - TipRanks
LivaNova names Stefano Folli as cardiopulmonary president By Investing.com - Investing.com South Africa
LivaNova names Stefano Folli to head cardiopulmonary unit - StreetInsider
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit - Business Wire
LivaNova PLC stock (US5356991077): cardiac device specialist in focus after regulatory update and ea - AD HOC NEWS
LivaNova’s SWOT analysis: medical device stock eyes growth plan By Investing.com - Investing.com Canada
LivaNova’s SWOT analysis: medical device stock eyes growth plan - Investing.com
LivaNova PLC Lifts 2026 Outlook After Strong Q1 - TipRanks
LivaNova stock hits 52-week high at 73.31 USD By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 73.31 USD - Investing.com India
LivaNova to present at Goldman Sachs Global Healthcare Conference in June - MSN
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June 2026 - BioSpace
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June - Business Wire
Will LivaNova's (LIVN) Return to Quarterly Profitability Reset Investor Expectations on Its Turnaround Narrative? - simplywall.st
LivaNova PLC stock (US5356991077): cardiac device maker updates investors after latest earnings - AD HOC NEWS
Total debt per share of LivaNova Plc – SWB:LIA - TradingView
LivaNova PLCOrdinary Shares (NQ: LIVN - FinancialContent
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ETFs Investing in LivaNova Plc Stocks - TradingView
LivaNova stock (US5356991077): Medical device leader with Nasdaq listing - AD HOC NEWS
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova (LIVN) Q3 2025 Earnings Transcript - AOL.com
LivaNova (LIVN) Stock Forum and Discussion - Moomoo
Drug Resistant Epilepsy Market to Reach US$ 1.28 Billion by 2033 - openPR.com
LivaNova stock hits 52-week high at 71.97 USD By Investing.com - Investing.com Nigeria
LivaNova PLC Lifts Guidance After Strong Q1 Call - TipRanks
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval - Yahoo Finance
LivaNova stock hits 52-week high at 71.97 USD - Investing.com India
LivaNova PLC 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LIVN) 2026-05-08 - Seeking Alpha
LivaNova PLC (LIVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Active Implantable Medical Devices Market Size is Anticipated - openPR.com
LIVN Maintained by Baird -- Price Target Lowered to $76.00 - GuruFocus
LIVN Maintained by Mizuho -- Price Target Raised to $90.00 - GuruFocus
LivaNova (LIVN) Q1 2025 Earnings Transcript - AOL.com
Q1 2026 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC (NASDAQ:LIVN) Q1 2026 Earnings Call Transcript - Insider Monkey
LivaNova Q1 2026 slides: double-digit growth drives guidance raise By Investing.com - Investing.com Australia
LivaNova revenue up 14.3% to USD 362.3M in Q1 2026 - Medical Buyer
LivaNova: Q1 Earnings Snapshot - theheraldreview.com
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):